Goker-Alpan O - Search Results

1

Time of Initiating Enzyme Replacement Therapy Affects Immune Abnormalities and Disease Severity in Patients with Gaucher Disease.

Limgala RP, Ioanou C, Plassmeyer M, Ryherd M, Kozhaya L, Austin L, Abidoglu C, Unutmaz D, Alpan O, Goker-Alpan O. Limgala RP, et al. PLoS One. 2016 Dec 12;11(12):e0168135. doi: 10.1371/journal.pone.0168135. eCollection 2016. PLoS One. 2016. PMID: 27942037 Free PMC article.

2

Therapeutic approaches to bone pathology in Gaucher disease: past, present and future.

Goker-Alpan O. Goker-Alpan O. Mol Genet Metab. 2011 Dec;104(4):438-47. doi: 10.1016/j.ymgme.2011.08.004. Epub 2011 Aug 11. Mol Genet Metab. 2011. PMID: 21889384 Free article. Review.

3

Commentary on "Pilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher disease" by Zimran et al.

Goker-Alpan O. Goker-Alpan O. Blood Cells Mol Dis. 2013 Feb;50(2):138-9. doi: 10.1016/j.bcmd.2012.09.007. Epub 2012 Oct 18. Blood Cells Mol Dis. 2013. PMID: 23083682 No abstract available.

4

A multicenter open-label treatment protocol (HGT-GCB-058) of velaglucerase alfa enzyme replacement therapy in patients with Gaucher disease type 1: safety and tolerability.

Pastores GM, Rosenbloom B, Weinreb N, Goker-Alpan O, Grabowski G, Cohn GM, Zahrieh D. Pastores GM, et al. Genet Med. 2014 May;16(5):359-66. doi: 10.1038/gim.2013.154. Epub 2013 Nov 21. Genet Med. 2014. PMID: 24263462 Free PMC article. Clinical Trial.

5

A pilot study of omalizumab in eosinophilic esophagitis.

Loizou D, Enav B, Komlodi-Pasztor E, Hider P, Kim-Chang J, Noonan L, Taber T, Kaushal S, Limgala R, Brown M, Gupta R, Balba N, Goker-Alpan O, Khojah A, Alpan O. Loizou D, et al. PLoS One. 2015 Mar 19;10(3):e0113483. doi: 10.1371/journal.pone.0113483. eCollection 2015. PLoS One. 2015. PMID: 25789989 Free PMC article. Clinical Trial.

6

Recommendations for the use of eliglustat in the treatment of adults with Gaucher disease type 1 in the United States.

Balwani M, Burrow TA, Charrow J, Goker-Alpan O, Kaplan P, Kishnani PS, Mistry P, Ruskin J, Weinreb N. Balwani M, et al. Mol Genet Metab. 2016 Feb;117(2):95-103. doi: 10.1016/j.ymgme.2015.09.002. Epub 2015 Sep 7. Mol Genet Metab. 2016. PMID: 26387627 Free article. Review.

7

Persistent immune alterations and comorbidities in splenectomized patients with Gaucher disease.

Sønder SU, Limgala RP, Ivanova MM, Ioanou C, Plassmeyer M, Marti GE, Alpan O, Goker-Alpan O. Sønder SU, et al. Blood Cells Mol Dis. 2016 Jul;59:8-15. doi: 10.1016/j.bcmd.2016.02.003. Epub 2016 Feb 15. Blood Cells Mol Dis. 2016. PMID: 27282561

8

New Directions in Gaucher Disease.

Horowitz M, Elstein D, Zimran A, Goker-Alpan O. Horowitz M, et al. Hum Mutat. 2016 Nov;37(11):1121-1136. doi: 10.1002/humu.23056. Epub 2016 Aug 21. Hum Mutat. 2016. PMID: 27449603 Review.

9

Enzyme replacement therapy reverses B lymphocyte and dendritic cell dysregulations in patients with Gaucher Disease.

Limgala RP, Jani C, Ioanou C, Alpan O, Goker-Alpan O. Limgala RP, et al. Blood Cells Mol Dis. 2018 Feb;68:81-85. doi: 10.1016/j.bcmd.2016.10.015. Epub 2016 Oct 28. Blood Cells Mol Dis. 2018. PMID: 27839980 Clinical Trial.

10

Gaucheromas: When macrophages promote tumor formation and dissemination.

Ivanova M, Limgala RP, Changsila E, Kamath R, Ioanou C, Goker-Alpan O. Ivanova M, et al. Blood Cells Mol Dis. 2018 Feb;68:100-105. doi: 10.1016/j.bcmd.2016.10.018. Epub 2016 Oct 27. Blood Cells Mol Dis. 2018. PMID: 27839983 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters